These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 8689806

  • 1. Buprenorphine and naloxone interactions in opiate-dependent volunteers.
    Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, Baggott MJ.
    Clin Pharmacol Ther; 1996 Jul; 60(1):105-14. PubMed ID: 8689806
    [Abstract] [Full Text] [Related]

  • 2. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J, Jones RT, Welm S, Brown J, Batki SL.
    Biol Psychiatry; 1997 Jun 01; 41(11):1095-101. PubMed ID: 9146820
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.
    Correia CJ, Walsh SL, Bigelow GE, Strain EC.
    Psychopharmacology (Berl); 2006 Dec 01; 189(3):297-306. PubMed ID: 17013637
    [Abstract] [Full Text] [Related]

  • 7. Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.
    Strain EC, Walsh SL, Bigelow GE.
    Psychopharmacology (Berl); 2002 Jan 01; 159(2):161-6. PubMed ID: 11862344
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers.
    Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP.
    Psychopharmacology (Berl); 1999 Jan 01; 141(1):37-46. PubMed ID: 9952063
    [Abstract] [Full Text] [Related]

  • 10. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers.
    Mintzer MZ, Correia CJ, Strain EC.
    Drug Alcohol Depend; 2004 May 10; 74(2):205-9. PubMed ID: 15099664
    [Abstract] [Full Text] [Related]

  • 11. Early experience with Suboxone maintenance therapy in Hungary.
    Demetrovics Z, Farkas J, Csorba J, Németh A, Mervó B, Szemelyácz J, Fleischmann E, Kassai-Farkas A, Petke Z, Oroján T, Rózsa S, Rigó P, Funk S, Kapitány M, Kollár A, Rácz J.
    Neuropsychopharmacol Hung; 2009 Dec 10; 11(4):249-57. PubMed ID: 20150662
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of an injection depot formulation of buprenorphine: placebo comparison.
    Sigmon SC, Wong CJ, Chausmer AL, Liebson IA, Bigelow GE.
    Addiction; 2004 Nov 10; 99(11):1439-49. PubMed ID: 15500597
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I, Vidal-Trécan G, Nabet N, Boissonnas A.
    Encephale; 2002 Nov 10; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [Abstract] [Full Text] [Related]

  • 19. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
    Stimolo C, Favero VD, Zecchinato G, Buson R, Cusin D, Pellachin P, Simonetto P.
    Clin Drug Investig; 2010 Nov 10; 30 Suppl 1():27-31. PubMed ID: 20450243
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.